AbCellera Biologics Inc. ABCL Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other intangible assets—net?
- AbCellera Biologics Inc. (ABCL) reported other intangible assets—net of $37.46M in Q1 2026.
- How has AbCellera Biologics Inc.'s other intangible assets—net changed year-over-year?
- AbCellera Biologics Inc.'s other intangible assets—net decreased by 9.1% year-over-year, from $41.19M to $37.46M.
- What is the long-term trend for AbCellera Biologics Inc.'s other intangible assets—net?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s other intangible assets—net has grown at a -19.7% compound annual growth rate (CAGR), from $115.15M to $38.38M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.